{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:25:28Z","timestamp":1787016328557,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1124\/jpet.118.256115","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T20:50:01Z","timestamp":1554238201000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose"],"prefix":"10.1016","volume":"371","author":[{"given":"Philip","family":"Krieter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwe","family":"Gyaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-815X","authenticated-orcid":false,"given":"Phil","family":"Skolnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.256115_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/bja\/85.4.533","article-title":"Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery","volume":"85","author":"Ahonen","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.118.256115_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/03007995.2017.1334637","article-title":"Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations","volume":"34","author":"Avetian","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.118.256115_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.118.256115_bib4","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/acschemneuro.8b00174","article-title":"DARK classics in chemical neuroscience: fentanyl","volume":"9","author":"Burns","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.118.256115_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"[(3)H]Alvimopan binding to the micro opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.256115_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/clpt.1986.9","article-title":"Nalmefene: intravenous safety and kinetics of a new opioid antagonist","volume":"39","author":"Dixon","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.118.256115_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","article-title":"Differences between opioids: pharmacological, experimental, clinical and economical perspectives","volume":"75","author":"Drewes","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.118.256115_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes","volume":"271","author":"Emmerson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.256115_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1213\/00000539-199403000-00021","article-title":"Comparison of potency and duration of action of nalmefene and naloxone","volume":"78","author":"Glass","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.118.256115_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0196-0644(05)80200-8","article-title":"Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study","volume":"22","author":"Kaplan","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.118.256115_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0196-0644(99)70270-2","article-title":"Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose","volume":"34","author":"Kaplan","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.118.256115_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/ALN.0000000000000634","article-title":"Opioid half-lives and hemlines: the long and short of fashion","volume":"122","author":"Kharasch","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.118.256115_bib13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jcph.759","article-title":"Pharmacokinetic properties and human use characteristics of an FDA-approved intranasal naloxone product for the treatment of opioid overdose","volume":"56","author":"Krieter","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.118.256115_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.annemergmed.2018.05.010","article-title":"Narcan or nar-can\u2019t: tips and tricks to safely reversing opioid toxicity","volume":"72","author":"Li","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.118.256115_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13346-012-0069-z","article-title":"High efficiency intranasal drug delivery using Intravail\u00ae alkylsaccharide absorption enhancers","volume":"3","author":"Maggio","year":"2013","journal-title":"Drug Deliv Transl Res"},{"key":"10.1124\/jpet.118.256115_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11419-017-0379-4","article-title":"Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil","volume":"36","author":"Misailidi","year":"2018","journal-title":"Forensic Toxicol"},{"key":"10.1124\/jpet.118.256115_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/pmt-2017-0060","article-title":"Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review","volume":"8","author":"Ryan","year":"2018","journal-title":"Pain Manag"},{"key":"10.1124\/jpet.118.256115_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2018.08.004","article-title":"On the front lines of the opioid epidemic: rescue by naloxone","volume":"835","author":"Skolnick","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.256115_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: one pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1124\/jpet.118.256115_bib21","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.118.256115_bib22","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1002\/phar.2117","article-title":"The pharmacokinetics and pharmacodynamics of carfentanil after recreational exposure: a case report","volume":"38","author":"Uddayasankar","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.118.256115_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.118.256115_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2014.05.044","article-title":"Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats","volume":"738","author":"Yong","year":"2014","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.256115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:57:48Z","timestamp":1739955468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524268828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0022356524268828"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.256115","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.256115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}